Effect of Extracorporeal Shock Wave in the Treatment of Knee Osteoarthritis
NCT ID: NCT03962270
Last Updated: 2019-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
36 participants
INTERVENTIONAL
2018-08-01
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extracorporeal Shockwave Therapy for Knee Osteoarthritis
NCT03048773
Shock Waves in Knee Arthritis
NCT06833372
Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis
NCT02904785
Radial Versus Focused Extracorporeal Shock Wave in the Treatment of Knee Osteoarthritis
NCT03921749
Effectiveness of Radial Extracorporeal Shock Wave Therapy in Patients With Knee Osteoarthritis
NCT06281444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
shock wave device
The experimental group (group ESWT) guided by ultrasound: conventional rehabilitation training is given priority to with strength training, application of pain when necessary, under the guidance of ultrasound ESWT treatment control group (routine rehabilitation group) : conventional rehabilitation training is given priority to with strength training, oral pain when necessary, under the guidance of ultrasound ESWT treatment (shock energy flow density of 0)
Control group
shock wave device
The experimental group (group ESWT) guided by ultrasound: conventional rehabilitation training is given priority to with strength training, application of pain when necessary, under the guidance of ultrasound ESWT treatment control group (routine rehabilitation group) : conventional rehabilitation training is given priority to with strength training, oral pain when necessary, under the guidance of ultrasound ESWT treatment (shock energy flow density of 0)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
shock wave device
The experimental group (group ESWT) guided by ultrasound: conventional rehabilitation training is given priority to with strength training, application of pain when necessary, under the guidance of ultrasound ESWT treatment control group (routine rehabilitation group) : conventional rehabilitation training is given priority to with strength training, oral pain when necessary, under the guidance of ultrasound ESWT treatment (shock energy flow density of 0)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MR prompt exist cartilage damage, there is no lack of full-thickness cartilage
* Kellgren - Lawrence (K - L) grade II - III grade
* The international association of cartilage repair cartilage damage grading system (ICRS) class I - III
* Informed consent and sign relevant documents
* Follow doctor's instructions and follow up on time
Exclusion Criteria
* Trauma of bone joint
* Inflammatory diseases
* Previous knee surgery history
* History of knee cavity injection in the past 6 months
* Serious cardiovascular diseases, pulmonary diseases or other serious diseases affecting survival, etc
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mouwang Zhou
senior professional post
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Univercity Third Hospital
Beijing, No State Or Province, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M2018089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.